Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia: What have Real-World Trials Taught Us?

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.6, 2012-06, pp. : 491-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effectiveness research: what future in the US?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

What's the real cost of preventing chronic disease in the US?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics cause diabetes mellitus in schizophrenia?

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Reversal of Left Ventricular Hypertrophy: What Have Recent Trials Taught Us?

By Paolo Verdecchia Fabio Angeli

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

The return of Tysabri to the market in the US?

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite